TLNRD1 is a CCM complex component and regulates endothelial barrier integrity
J Cell Biol. 2024 Sep 2;223(9):e202310030. doi: 10.1083/jcb.202310030. Epub 2024 Jul 16.
Published on July 16, 2024
ABSTRACT
We previously identified talin rod domain-containing protein 1 (TLNRD1) as a potent actin-bundling protein in vitro. Here, we report that TLNRD1 is expressed in the vasculature in vivo. Its depletion leads to vascular abnormalities in vivo and modulation of endothelial cell monolayer integrity in vitro. We demonstrate that TLNRD1 is a component of the cerebral cavernous malformations (CCM) complex through its direct interaction with CCM2, which is mediated by a hydrophobic C-terminal helix in CCM2 that attaches to a hydrophobic groove on the four-helix domain of TLNRD1. Disruption of this binding interface leads to CCM2 and TLNRD1 accumulation in the nucleus and actin fibers. Our findings indicate that CCM2 controls TLNRD1 localization to the cytoplasm and inhibits its actin-bundling activity and that the CCM2-TLNRD1 interaction impacts endothelial actin stress fiber and focal adhesion formation. Based on these results, we propose a new pathway by which the CCM complex modulates the actin cytoskeleton and vascular integrity.
PMID:39013281 | PMC:PMC11252447 | DOI:10.1083/jcb.202310030
Latest Publications
- Testosterone Exposure During Fetal Masculinization Programming Window Determines the Kidney Size in Adult Mice
- Genomic history of early dogs in Europe
- miR-199a-3p Promotes Adipogenic Differentiation to Aggravate Steroid-Induced Osteonecrosis of Femoral Head via the ITGB8/FAK-ERK/RUNX2 Pathway
- Macrophages restrict tumor immune infiltration by controlling collagen topography
- Fluorine-18-Labeled Nucleotide Analogs Targeting Ecto-5′-Nucleotidase (CD73) for Positron Emission Tomography Imaging of Solid Tumors